Tags: Drug.

Etazolate (SQ-20009 EHT-0202) is an anxiolytic drug which is a pyrazolopyridine derivative and has unique pharmacological properties. It acts as a positive allosteric modulator of the GABAA receptor at the barbiturate binding site as an adenosine antagonist of the A1 and A2 subtypes and as a phosphodiesterase inhibitor selective for the PDE4 isoform. It is currently in clinical trials for the treatment of Alzheimer’s disease.

Etazolate.svg
ATC prefix
none
CAS number
51022-77-6
FDA UNII code
I89Y79062L
IUPAC name
Ethyl 1-ethyl-4-[2-(propan-2-ylidene)hydrazinyl]-1H-pyrazolo[34-b]pyridine-5-carboxylate
PubChem
3277

Loading...

This page contains content from the copyrighted Wikipedia article "Etazolate"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.